Literature DB >> 29570165

Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.

Christine E Haugen1, Alvin G Thomas1, Jacqueline Garonzik-Wang1, Allan B Massie1,2, Dorry L Segev1,2.   

Abstract

BACKGROUND: Allografts from older liver donors (OLDs), 70 years or older are often discarded for fear of inferior outcomes. We previously identified "preferred recipients" who did not suffer the higher risk of graft loss and mortality associated with OLDs. Preferred recipients were first-time, non-status 1 registrants older than 45 years, body mass index less than 35, indication other than hepatitis C, and cold ischemia time less than 8 hours.
METHODS: We assessed the validity of the preferred recipient construct in a larger, more recent cohort (38 891 patients, 2006-2013). We compared recipients of OLD grafts to recipients of average liver donors (ALDs, age = 40-69) and ideal liver donors (ILDs, age = 18-39) grafts using multilevel Cox regression adjusting for recipient and transplant factors.
RESULTS: The use of OLD grafts in preferred recipients has increased from 2006 to 2013 (P = 0.02). Preferred recipients Model for End-Stage Liver Disease scores ranged 6 to 40. Preferred recipients had similar 5-year all-cause graft loss (ACGL) with OLD versus ALD and ILD grafts (25.4% vs 24.5% and 21.6%). Conversely, nonpreferred recipients had higher 5-year ACGL with OLD versus ALD and ILD grafts (41.4% vs 32.9% and 25.6%). After adjustment, preferred recipients had similar graft loss with OLD versus ALD grafts (hazard ratio [HR], 0.921.081.27; P = 0.3) and ILD grafts (HR, 0.981.161.39, P = 0.09); however, nonpreferred recipients had higher ACGL risk with OLD grafts versus ALD (HR, 1.281.411.56, P < 0.001) and ILD grafts (HR, 1.501.671.86, P < 0.001). Similar trends are seen with mortality.
CONCLUSIONS: Because preferred recipients comprise 43.3% (n = 2916) of the current waitlist and span the full range of Model for End-Stage Liver Disease scores, transplanted OLD allografts could be distributed without added risk of graft loss or mortality.

Entities:  

Mesh:

Year:  2018        PMID: 29570165      PMCID: PMC6102054          DOI: 10.1097/TP.0000000000002190

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  26 in total

1.  How can we define expanded criteria for liver donors?

Authors:  Robert M Merion; Nathan P Goodrich; Sandy Feng
Journal:  J Hepatol       Date:  2006-07-31       Impact factor: 25.083

2.  Effective communication of standard errors and confidence intervals.

Authors:  Thomas A Louis; Scott L Zeger
Journal:  Biostatistics       Date:  2008-06-10       Impact factor: 5.899

Review 3.  Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation.

Authors:  S M Strasberg; T K Howard; E P Molmenti; M Hertl
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

Review 4.  Big data in organ transplantation: registries and administrative claims.

Authors:  A B Massie; L M Kucirka; L M Kuricka; D L Segev
Journal:  Am J Transplant       Date:  2014-08       Impact factor: 8.086

5.  Expanding the Margins: High Volume Utilization of Marginal Liver Grafts Among >2000 Liver Transplants at a Single Institution.

Authors:  Karim J Halazun; Ralph C Quillin; Russel Rosenblatt; Advaith Bongu; Adam D Griesemer; Tomoaki Kato; Craig Smith; Fabrizio Michelassi; James V Guarrera; Benjamin Samstein; Robert S Brown; Jean C Emond
Journal:  Ann Surg       Date:  2017-09       Impact factor: 12.969

6.  OPTN/SRTR 2015 Annual Data Report: Liver.

Authors:  W R Kim; J R Lake; J M Smith; M A Skeans; D P Schladt; E B Edwards; A M Harper; J L Wainright; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2017-01       Impact factor: 8.086

7.  Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era.

Authors:  Valentina Rosa Bertuzzo; Matteo Cescon; Federica Odaldi; Marco Di Laudo; Alessandro Cucchetti; Matteo Ravaioli; Massimo Del Gaudio; Giorgio Ercolani; Antonietta D'Errico; Antonio Daniele Pinna
Journal:  Ann Surg       Date:  2017-02       Impact factor: 12.969

8.  Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis.

Authors:  Manish G Amin; Michael P Wolf; John A TenBrook; Richard B Freeman; Steve J Cheng; Daniel S Pratt; John B Wong
Journal:  Liver Transpl       Date:  2004-12       Impact factor: 5.799

9.  Minimizing risk associated with elderly liver donors by matching to preferred recipients.

Authors:  Dorry L Segev; Warren R Maley; Christopher E Simpkins; Jayme E Locke; Geoffrey C Nguyen; Robert A Montgomery; Paul J Thuluvath
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

10.  Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death.

Authors:  Eric S Orman; A Sidney Barritt; Stephanie B Wheeler; Paul H Hayashi
Journal:  Liver Transpl       Date:  2013-01       Impact factor: 5.799

View more
  9 in total

1.  Donor-Recipient Matching Is Important but Age Matching Alone Is Insufficient.

Authors:  Christine E Haugen; Dorry L Segev
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

2.  The relationship between the C-statistic and the accuracy of program-specific evaluations.

Authors:  Andrew Wey; Nicholas Salkowski; Bertram L Kasiske; Melissa A Skeans; Sally K Gustafson; Ajay K Israni; Jon J Snyder
Journal:  Am J Transplant       Date:  2018-10-29       Impact factor: 8.086

3.  Minimizing Risks of Liver Transplantation with Steatotic Donor Livers by Preferred Recipient Matching.

Authors:  Kyle R Jackson; Jennifer D Motter; Christine E Haugen; Jane J Long; Betsy King; Benjamin Philosophe; Allan B Massie; Andrew M Cameron; Jacqueline Garonzik-Wang; Dorry L Segev
Journal:  Transplantation       Date:  2019-11-20       Impact factor: 4.939

4.  Survival benefit of accepting livers from deceased donors over 70 years old.

Authors:  Christine E Haugen; Mary G Bowring; Courtenay M Holscher; Kyle R Jackson; Jacqueline Garonzik-Wang; Andrew M Cameron; Benjamin Philosophe; Mara McAdams-DeMarco; Dorry L Segev
Journal:  Am J Transplant       Date:  2019-01-25       Impact factor: 8.086

5.  The landscape of international living kidney donation in the United States.

Authors:  Fawaz Al Ammary; Alvin G Thomas; Allan B Massie; Abimereki D Muzaale; Ashton A Shaffer; Brittany Koons; Mohamud A Qadi; Deidra C Crews; Jacqueline Garonzik-Wang; Hai Fang; Daniel C Brennan; Krista L Lentine; Dorry L Segev; Macey L Henderson
Journal:  Am J Transplant       Date:  2019-02-08       Impact factor: 8.086

6.  Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016.

Authors:  Christine E Haugen; Courtenay M Holscher; Xun Luo; Mary Grace Bowring; Babak J Orandi; Alvin G Thomas; Jacqueline Garonzik-Wang; Allan B Massie; Benjamin Philosophe; Mara McAdams-DeMarco; Dorry L Segev
Journal:  JAMA Surg       Date:  2019-05-01       Impact factor: 14.766

7.  How Old Is Old? An Age-Stratified Analysis of Elderly Liver Donors above 65.

Authors:  Philipp Houben; Eike Bormann; Felicia Kneifel; Shadi Katou; Mehmet Haluk Morgül; Thomas Vogel; Ralf Bahde; Sonia Radünz; Andreas Pascher; Hartmut Schmidt; Jens Gunther Brockmann; Felix Becker
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

8.  Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.

Authors:  Kyle R Jackson; Jennifer D Motter; Christine E Haugen; Jane J Long; Betsy King; Benjamin Philosophe; Allan B Massie; Andrew M Cameron; Jacqueline Garonzik-Wang; Dorry L Segev
Journal:  Transplantation       Date:  2020-08       Impact factor: 5.385

9.  A Clinical Tool to Guide Selection and Utilization of Marginal Donor Livers With Graft Steatosis in Liver Transplantation.

Authors:  Justin A Steggerda; Daniel Borja-Cacho; Todd V Brennan; Tsuyoshi Todo; Nicholas N Nissen; Matthew B Bloom; Andrew S Klein; Irene K Kim
Journal:  Transplant Direct       Date:  2022-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.